The U.S. Is One Step Closer To Having New COVID-19 Booster Shots Available As Soon As This Fall.

Drugmakers Pfizer and BioNTech announced that they've asked the Food and Drug Administration to authorize an updated version of their COVID-19 vaccine — this one designed specifically to target the omicron subvariants that are dominant in the U.S.